new combination therapies in her2-expressing gastric cancer
Published 4 months ago • 84 plays • Length 1:01Download video MP4
Download video MP3
Similar videos
-
3:12
advances in her2-targeted therapies for gastric cancer
-
1:34
destiny-gastric03: t-dxd in her2 and her2-low gastric cancer
-
2:15
treatments for her2 esophagogastric cancer
-
0:54
targeted treatment for gastric cancer beyond her2
-
1:28
advances in biomarker-directed therapies for gastric cancer
-
2:39
first line immunotherapy/chemotherapy in her2- gastric cancer in japan
-
2:13
zanidatamab chemo as 1l therapy in her2-expressing gea
-
1:58
destiny-gastric02: t-dxd as a second-line treatment for her2-positive gastric cancer
-
4:41
destiny-gastric03: trastuzumab deruxtecan in her2-overexpressing gastric cancer
-
59:18
optimizing novel her2-targeted therapies and other agents in gastric cancer care
-
35:36
personalized treatment of advanced her2-negative gastric or gastroesophageal junction cancer
-
1:07:30
personalizing gastric cancer care with her2-targeted and other novel therapies
-
1:43
gasther2: trastuzumab for advanced gastric cancer
-
5:46
mahogany: margetuximab in gastric cancer
-
1:04
ttx-030, budigalimab, and folfox combination therapy in advanced or metastatic gastric/gej cancer
-
2:19
asco gi 2021: her2-positive gastric cancer, polo and key trials in progress
-
1:40
keynote-811: trastuzumab chemotherapy with or without pembrolizumab for her2 g/gej cancer
-
7:53
novel and combination therapies for the treatment of gastric cancer
-
1:18:52
her2-positive gastrointestinal cancers: new evidence and practical guidance with targeted agents